Raising Awareness about
Shift Work Disorder
As part of its national awareness initiative about shift work disorder, Cephalon
encourages the public to recognize those who work non-traditional hours by sharing
with family and friends the short video, "Shift Your Assumptions."
Watch the video
>>
New Survey Highlights Toll of Working Nontraditional Shifts
Survey results released by Men’s Health Network and Cephalon found that shift
workers report that their work schedules can negatively impact their health, work
and well-being.
Find out how shift workers
responded >>
Framing Life With Lymphoma
Cephalon partners with the Cancer Support Community to launch a new program to improve communication between healthcare professionals and their patients, from diagnosis through treatment.
Spreading Awareness on Safe Use
Cephalon has expanded its advocacy program to educate patients, caregivers and the public on the appropriate use of prescription medicines.Read more >>
When Good Medicines Become
Bad DrugsSM
Experts in the pain community discuss the importance of understanding the safe and appropriate use of prescription medicines.
Cephalon Establishes the Frank Baldino, Jr. Endowed Scholarship Fund
Created in honor of Cephalon’s founder, the scholarship will provide support
for qualifying medical and Ph.D. students at the Temple University School of Medicine.
Get details >>
Margaret Hansen Frogge, RN, MS, President, ONS Foundation
On the partnership between Cephalon and the Oncology Nursing Society (ONS) Foundation. Read more >>
Teva Completes Acquisition of Cephalon
Combined organization will provide customers with a broad spectrum of specialty branded products in addition to the world's largest generic drug portfolio
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today that it has completed its acquisition of Cephalon, Inc. The combined company will have a significant presence in over 60 countries and generated approximately $20 billion in revenues on a pro-forma basis for the twelve months ended June 2011.